Singapore: Indonesian Children may have to go through the pain of vaccination again as there is a recent police discover...
Tokyo: North American pharmaceutical companies Protein Sciences Corporation and UMN Pharma Inc. have announced that Prot...
Singapore: Teva Pharmaceuticals has announced a voluntary recall of one lot of amikacin sulfate injection USP, 1 gram/4m...
Singapore: ABIVAX, Europe-based clinical stage biopharmaceutical company developing and commercializing anti-viral compo...
Singapore: The global Respiratory Syncytial Virus (RSV) treatment market will expand to unprecedented levels over the ne...
Japan's Takeda Pharmaceutical Company Limited has announced a partnership with the Bill & Melinda Gates Foundation t...
Singapore: Merck (MSD) has recieved US Food and Drug Administration (FDA) approval for Bridion (sugammadex) Injection 10...
Singapore: Australian infectious disease therapy and vaccine development company BioDiem has signed an agreement to lice...
Singapore: Scientists at Melbourne University and University of California have found that mosquito that are infected wi...
Singapore: Japan's drug major Takeda Pharmaceutical has said that they are set to finish the early stage human studies o...
Singapore: According to a recent decision publicized by the Chinese government, wholesalers will no longer be allowed to...
Singapore: Yisheng Biopharma, China based biopharmaceutical company, has recieved positive topline results from Phase I ...
Singapore: China based Hualan Bio has recieved world health organization (WHO) pre-qualification approval for influenza ...
Singapore: Japan's Teikoku Pharma has recieved USFDA approval for Docetaxel injection, a non-alcohol formula for the tre...
Singapore: Germany based complex biologics development and manufacturing specialist, ProBioGen, has proceeded on the cli...
Singapore: In a recent interim study published in the Lancet medical journal, Merck's Ebola vaccine was found to be "hig...
Singapore: Teva Parenteral Medicines has recalled six lots of Adrucil (fluorouracil injection) due to the potential pres...
The current anti-malarial market in India is approximately $80 million (Rs 450 crore) with an annual growth rate of 17 p...
